Reviva Pharmaceuticals Holdings's total assets for Q3 2024 were $7.63M, a decrease of -5.25% from the previous quarter. RVPH total liabilities were $17.61M for the fiscal quarter, a 24.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.